Month: October 2012

The use of stimulant medications for the treatment of Adult ADHD has increased tremendously. I now see many psychiatrists in the community prescribing them along with antidepressants in those without ADHD. Before you commit to the use of stimulant medications here are ten things you need to now—some reassuring and some not. 1. They’re popular:… Read More

So does my bupropion XL even work? That is the question my patients have been asking the last two weeks. I wonder too. Here is what we know thus far: • On October 3, 2012, the FDA announced that Budeprion XL 300 mg (bupropion extended-release tablets), marketed by Teva Pharmaceuticals, is not therapeutically equivalent to… Read More

A new long acting inhaler has been approved for the treatment of Chronic Obstructive Pulmonary Disease (COPD). The new inhaler, Tudorza Pressair, is due to come out this year and compete with Spiriva. The active ingredient in this new inhaler is aclidinium, a long-acting anticholinergic agent that was approved by the FDA for long-term maintenance… Read More

Many have been waiting for a pill for MS, and here it is. Injectables (Avonex, Betaseron, Copaxone and Rebif) are currently the mainstay of treatment for MS, so realize that most MS patients are currently injecting themselves once daily or once a week. Now, there may be a pill option. This month the Food and… Read More

When you hear about Exalgo you may wonder why we need such a high dose of hydromorphone in one pill, and you may feel worried about that. Well, physicians feel the same way. Here is the deal. Dilaudid is the short acting hydromorphone most people are familiar with. In August 2012, the Food and Drug… Read More